1 / 56

Headache: A Worldwide Problem

Headache: A Worldwide Problem. Up to 25% of American adults have a severe headache each year Up to 4% have daily or near-daily headache Lifetime prevalence: 90% or more Significant suffering and economic loss. Headache: A Local Problem. Average visit length: 3.5 hours.

sandrajolly
Download Presentation

Headache: A Worldwide Problem

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Headache: A Worldwide Problem • Up to 25% of American adults have a severe headache each year • Up to 4% have daily or near-daily headache • Lifetime prevalence: 90% or more • Significant suffering and economic loss

  2. Headache: A Local Problem • Average visit length: 3.5 hours

  3. Barriers To Success • Limited physician training • Limited access to care • Inappropriate or incomplete treatment • Underestimation of morbidity

  4. Ambulatory Care Innovation Grant • Funding from UW Medical Foundation • Goal: • Improve pain care referral, triage and utilization across UW Health • First step: • Survey physicians, nurses, and midlevel providers about their comfort with and use of pain management

  5. Staff Survey Results • Key areas • Reduce emergency department utilization for non-emergency pain care • Improve pain education for staff at all levels • Improve communication of pain-related information across UW Health • Centralize pain referral and case triage • Improve coordination of perioperative pain care

  6. Staff Survey Results • Key areas • Reduce emergency department utilization for non-emergency pain care • Improve pain education for staff at all levels • Improve communication of pain-related information across UW Health • Centralize pain referral and case triage • Improve coordination of perioperative pain care

  7. Goals 2006 – 2007 • Familiarize primary care and emergency room providers with basic headache management • Educate patients • Standardize treatment protocols • Standardize communication of headache care plans • Incorporate care plans, protocols and educational tools into EMR

  8. Provider Toolkit • Video on Headache Care Basics (DVD and online) • Introductory article on headache • Headache diagnostic classification • Madison citywide headache treatment guidelines • Headache treatment plan form • Headache Clinic consult request form downloadable from uconnect and uwhealth.org

  9. Headache Treatment Guidelines • Developed by panel of specialists • Provides a framework for headache treatment, particularly migraine uconnect: Clinical Guidelines / Pain Management Resources

  10. Headache Treatment Plan • Outline patient’s individual treatment plan • One copy scanned into EMR • Copy 2 – give to patient Standard Register #SR300078

  11. When To Call The Headache Clinic? • Refractory headache • Unclear diagnosis • Intensive and/or interdisciplinary treatment needed 608-263-9550 Consult Form – Standard Register #SR300077

  12. Patient Toolkit • Video on Headache Basics (DVD and online) • Introductory letter • Headache Diary • Health Facts • Migraine; Medication Overuse Headache; Diet and Headache; Avoiding the ED downloadable from uconnect and uwhealth.org

  13. Headache Diary • Patient fills this out daily • Brings to clinic visit • Lets you evaluate headache pattern and treatment effects Standard Register #SR300079

  14. Basic Principles • Rule out potentially dangerous (secondary) headache • Neoplasm, infection, hemorrhage, etc. • Thorough history and physical • Diagnose headache type • Implement treatment • Monitor outcome

  15. Secondary Headache Disorders • <2% of headaches in primary care offices • Head trauma • Vascular disease • Neoplasms • Substance abuse or withdrawal • Infection/Inflammation • Metabolic disorders • others

  16. “Warning Signs” • first or worst HA (“thunderclap headache”) • progressive or new daily persistent HA • age >50 or <5 years • HA associated with fever, rash, stiff neck • HA associated with abnormal mental status or abnormal neuro exam

  17. “Warning Signs” • HA associated with papilledema • new HA in patient with h/o malignancy, immunosuppression/HIV, pregnancy • awakening because of HA • HA with Valsalva or exertion

  18. Primary Headache • Intrinsic dysfunction of the nervous system • Most patients presenting to PCP with headache have primary headache syndromes • Episodic headache: more common • Chronic headache: attacks occurring more frequently than 15 days/month for more than 6 months

  19. Diagnostic Steps • Rule out secondary headache • Thorough history • Neurological and musculoskeletal examinations • Imaging, blood work and/or CSF analysis if “red flag(s)” found • Diagnose headache type • Identify comorbid illnesses

  20. Headache History • Area of head involved • Pain quality • Pain severity • Other symptoms (nausea, vomiting, light sensitivity) • Triggers • Timing (including perimenstrual) • Pre-headache warning symptoms (“aura”) – for example, visual changes

  21. Migraine Pathophysiology • Migraine is a brain disorder • Brain becomes hypersensitive and overly responsive to stimuli • The trigeminal nerve appears to be a key pathway

  22. Migraine Cascade • Vasoactive substances inflame vascular and meningeal tissue, activate trigeminal axons • Perivascular release of vasoactive neuropeptides; spreading neurogenic inflammation

  23. Migraine Cascade • Pain signals reach trigeminal nucleus caudalis and other pain systems • Dorsal raphe nucleus may modulate migraine pain • The inflammatory response spreads along the trigeminovascular system

  24. Migraine • Episodic, progressive head pain • Pulsating, throbbing, stabbing • Attacks: 4-72 hours • Unilateral in 60% • Up to 75% may have neck pain

  25. Migraine • 3 : 1 female : male • 6% of males, 18% of females, 4% of children • Family history + in 80-90% • Onset typically during adolescence or young adulthood • Onset after age 40 possible

  26. Migraine Triggers • Hormonal fluctuations • Perimenstrual migraine very common • Weather changes • Diet, including missed meals • Stress

  27. Migraine Subtypes • Migraine with aura (20%) • Neurologic event precedes migraine (usually by 30-60 minutes) • Visual, auditory, olfactory disturbances • Migraine without aura • No aura or other warning symptoms • Chronic migraine

  28. Chronic Migraine • Starts as episodic migraine • Attacks occur at increasing frequency • Eventually 15+ attacks/month • Frequent association with medication overuse • Psych comorbidity common

  29. Medication Overuse Headache • Persistent, recurring headache in the setting of regular analgesic use • Continues until medication is stopped • Often responsible for “transformation” of episodic into chronic headache Ingredients: Succinic acid, fumaric acid, dextrose and bioflavonoids

  30. Overuse Headache: Features • Short-acting analgesic use more than 2-3 times/week • Headaches become predictable, more frequent, even continuous • Medications no longer prevent headaches

  31. Common Culprits • Analgesics, especially short- or intermediate-acting • Opioids • NSAIDs including acetaminophen • Combination analgesics • Caffeine • Triptans • Hormones: OCPs, others

  32. Tension-Type Headache • Episodic or chronic; possible migraine variant • Episodic form affects up to 38% of US adults annually • Less disability and morbidity than migraine, so less seen by MDs

  33. Tension-Type Headache • “Bandlike” • Bilateral: frontal, temporoparietal • Referred (myofascial) pain from neck to head • Neck structures may contribute to pain (“cervicogenic headache”)

  34. Cluster Headache • Rare disorder • M:F 3:1; genetic predisposition • Cycles/clusters lasting weeks to months • Repetitive headaches during a cluster • 1-3 hours apiece; always unilateral • Focal facial and eye pain, lacrimation, rhinorrhea • Often occur when sleeping or napping

  35. Cluster Headache • “CH face”: leonine face, furrowed and thickened skin with prominent folds, a broad chin, vertical forehead creases, and nasal telangiectasias. • Typically tall and rugged-looking

  36. Chronic Daily Headache • Chronic migraine • Chronic tension-type headache • New daily, persistent headache • Generally poor prognosis • Hemicrania continua • Unilateral, persistent • Some migraine features; head trauma in 20%

  37. Treatment: Define Goals • Patient’s goals • Pain relief; medication; ? improved function • Your goals • Pain relief or reduction; improved function; appropriate medication use • Bring goals into congruence

  38. Treatment Plan • Preventive therapy • Abortive therapy • Pre-emptive therapy • Short-term to prevent anticipated headache • Urgent (“rescue”) therapy • Minimize or eliminate where possible

  39. Non-Drug Treatment • Learn appropriate prevention and treatment • Avoid headache triggers: foods, drugs, activities • Avoid frequent abortive treatment • Stop smoking • Normalize sleeping and eating • Exercise • Relaxation and biofeedback • Psychotherapy

  40. Rehabilitation • Treat postural dysfunction and myofascial pain • Relaxation training • Physical therapy • Reduce spasm • Improve posture • Reduce triggers/perpetuating factors

  41. Eliminate Overuse Headache • Taper and stop offending agents • Severe headache invariably results • Supportive treatment: hydration, antiemetics, anti-withdrawal agents if needed • Initiate preventive therapy as taper begins • Initiate nondrug therapies • Add abortive therapy once withdrawal headache passes

  42. Migraine: Preventive Treatment • Tricyclic antidepressants – first-line • Amitripyline, doxepin if sleep is disturbed • Beta-blockers – first-line • Atenolol, nadolol • Ca++ channel blockers – less effective • Verapamil most commonly used

  43. Migraine: Preventive Treatment • Anticonvulsants – second-line; valuable • Valproate and topiramate are quite effective • Gabapentin – best tolerated, ? effect • Lamotrigine, levetiracetam – no good data as yet • Pregabalin – may help (anecdotal) • Psychotropic effects may be useful

  44. Migraine: Preventive Treatment • Ergots: Rarely used for prevention • Side effects may be problematic • Methysergide: fibrosis (use 6 months max) • MAOIs: Can be very effective • Tyramine-free diet a must • Numerous drug interactions

  45. Migraine: Abortive Treatment • Simple and combined analgesics • APAP, NSAIDs, others • Mixed analgesics (barbiturate plus simple analgesics) – avoid wherever possible • Ergot derivatives • Triptans • Opioids

  46. Triptans • Serotonin 5-HT1 agonists • Reduce neurogenic inflammation • Most effective if used at onset of headache or aura, though may be helpful at other phases • Used specifically for migraine • For nonresponders, try ergots (also act on NE, DA, other receptors)

  47. Triptans • Generally well tolerated • Contraindications: • Uncontrolled hypertension • CAD, PVD, cerebrovascular disease • Pregnancy • MAOIs • High-dose SSRIs, tramadol (rare interaction) • Ergotamine or other triptan use within 24 hrs

  48. Triptans • Short-acting • Sumatriptan, almotriptan, rizatriptan, zolmitriptan, eletriptan • Longer half-lives • Naratriptan, frovatriptan • Successive trials may be needed to determine the best triptan for a given patient

  49. DHE • Nasal spray • Administer each nostril, may repeat in 15 minutes • Works best if taken early • Longer half-life than sumatriptan, though not as reliable for some patients • Injection • 1 mg can be given SQ or IM • Max dose: 3 mg/24 hours

  50. Other Agents • Antiemetics/Neuroleptics: often combined with abortive agents • Prochlorperazine, hydroxyzine, promethazine, metoclopramide • Chlorpromazine and other neuroleptics may be effective alone

More Related